From recognising early signs to caregiving boundaries, experts and carers share practical strategies for supporting people ...
Neurocrine Biosciences ($NBIX) announced an update on their ongoing clinical study. Neurocrine Biosciences has initiated a Phase 3 study titled ‘A ...
Dual art therapy, combining music and painting, significantly improved symptoms, cognitive function, and quality of life in ...
As per previous communication, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) had informed Anavex about a negative trend-vote following its oral examination in ...
Cobenfy’s efficacy at treating the symptoms of patients with psychosis may vary between subgroups, according to a post-hoc ...
As treatment for schizophrenia changes, LAIs are becoming increasingly important as maintenance therapy. Teva's pursuit of an ...
Adjunctive treatment with the GLP-1 agonist semaglutide significantly reduces the antipsychotic-related cardiometabolic risk ...
Individuals with psychiatric disorders exhibiting seemingly similar symptoms often respond very differently to the same treatment, suggesting that distinct biological processes are at work beneath the ...
Introduction Prescribing high-dose antipsychotics is typically reserved for individuals with treatment-resistant severe ...
Researchers discovered that some variants of the gene known as GRIN2A can cause certain conditions all on their own.
Research links variations in the gene GRIN2A to a higher risk of developing schizophrenia and other forms of mental illness.
Semaglutide medications like Ozempic and Wegovy can help lower the risk of heart and metabolic diseases in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback